Edition:
United Kingdom

Ambu A/S (AMBUb.CO)

AMBUb.CO on Copenhagen Stock Exchange

118.20DKK
3:59pm GMT
Change (% chg)

kr.-1.10 (-0.92%)
Prev Close
kr.119.30
Open
kr.119.30
Day's High
kr.120.00
Day's Low
kr.116.20
Volume
481,959
Avg. Vol
399,975
52-wk High
kr.135.00
52-wk Low
kr.55.32

Chart for

About

Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area... (more)

Overall

Beta: 0.45
Market Cap(Mil.): kr.23,432.60
Shares Outstanding(Mil.): 41.84
Dividend: 1.55
Yield (%): 0.28

Financials

  Industry Sector
P/E (TTM): -- 32.19 16.64
EPS (TTM): -- -- --
ROI: -- 13.90 10.66
ROE: -- 16.72 14.30

BRIEF-Ambu Q1 EBIT up at DKK 91 MLN

* ‍OUR OUTLOOK ON EARNINGS AND FREE CASH FLOWS FOR YEAR ARE RAISED.​

31 Jan 2018

BRIEF-Ambu Reduces Nominal Value Of Each A And B Share​

* ‍DECIDED TO REDUCE NOMINAL VALUE OF EACH A AND B SHARE FROM DKK 2.50 PER SHARE TO DKK 0.50 PER SHARE.​

18 Dec 2017

BRIEF-Ambu A/S says to issue up to 1.3 mln B shares in private placement

* Reg-Ambu A/S: Ambu A/S to issue up to 1,255,000 B shares in a private placement Source text for Eikon: Further company coverage: ( Bangalore.newsroom@thomsonreuters.com )

14 Nov 2017

BRIEF-Ambu Q4 2016/17 EBIT up at DKK ‍134​ million

* Q4 2016/17 EBIT DKK ‍134​ MILLION VERSUS DKK 131 MILLION YEAR AGO

09 Nov 2017

BRIEF-Ambu buys Invendo Medical for EUR 225 million

* REG-AMBU ACQUIRES INVENDO MEDICAL AND ENTERS MARKET OF 70 MILLION GASTRO PROCEDURES ANNUALLY

25 Oct 2017

BRIEF-Ambu plans to ‍generate an EBIT margin of 24-25 pct in 2020

* ‍TOWARDS 2020 AMBU PLANS TO GROW ORGANICALLY BY 13-15% ANNUALLY AND EXPAND EBIT-MARGIN BY MORE THAN 5%-PTS​

04 Oct 2017

BRIEF-Ambu Q3 2016/17 EBIT up at DKK 130 million

* ‍OUTLOOK IS NOW FOR ORGANIC GROWTH OF APPROX. 14% AGAINST PREVIOUSLY ANNOUNCED OUTLOOK OF 12-14%​

23 Aug 2017

Earnings vs. Estimates